$106 Million is the total value of HealthInvest Partners AB's 9 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $19,562,000 | +20.7% | 1,520,000 | +4.8% | 18.54% | +43.6% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $16,319,000 | +16.7% | 530,000 | -0.7% | 15.46% | +38.9% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $10,485,000 | +39.4% | 52,000 | +48.6% | 9.94% | +65.9% |
| ARAY | Buy | ACCURAY INC | $10,396,000 | +6.3% | 2,300,000 | +16.5% | 9.85% | +26.5% |
| MCK | Buy | MCKESSON CORP | $9,944,000 | +54.5% | 52,000 | +57.6% | 9.42% | +83.8% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $9,823,000 | +55.6% | 147,000 | +47.0% | 9.31% | +85.1% |
| CI | Buy | CIGNA CORP NEW | $9,720,000 | +54.7% | 41,000 | +57.7% | 9.21% | +84.0% |
| CAH | Buy | CARDINAL HEALTH INC | $9,705,000 | +53.6% | 170,000 | +63.5% | 9.20% | +82.8% |
| ABBV | Buy | ABBVIE INC | $9,574,000 | +28.2% | 85,000 | +23.2% | 9.07% | +52.5% |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -85,000 | -100.0% | -5.09% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -55,000 | -100.0% | -5.17% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -54,000 | -100.0% | -5.74% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -46,000 | -100.0% | -6.13% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -2,000,000 | -100.0% | -6.23% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -660,000 | -100.0% | -7.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.